Data Snapshot: Nov 03, 2026
$100K+

Oct-2026

Sales

Strong Growth

Trend

6-Month

26

Product Count

SKUs

$13.23

Avg Price

81.6%

YoY Sales Change

4%

YoY Price Change

How loyal are cannabis customers to the brands they buy? See retention benchmarks by category and state →
For brands

Is this your brand?

See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.

See your brand's data
For retailers

Carry this brand in your store?

Headset Retailer is free. Connect your POS and see what's selling and what's sitting.

Sign up free
SUNO

Where to Buy

SUNO is stocked at 214 licensed dispensaries across Michigan and Arizona, 176 of them in Michigan, with the deepest coverage in New Buffalo, Monroe, Lansing, Detroit, and Kalamazoo. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/14172.json?v=20261102
SUNO Sales

Market Insights Snapshot

SUNO Historical Sales by Category

In October 2026, SUNO’s category mix concentrated in Tincture & Sublingual at 46.6% share with 236.7% year-over-year growth and a 2.2% month-over-month uptick, while Capsules held 24.5% share with 55.4% year-over-year growth but a 17.9% month-over-month decline. Concentrates accounted for 23.4% share with 0.3% year-over-year growth and a 24.3% month-over-month drop, and Topical carried 5.5% share with 157.2% year-over-year growth and an 8.7% month-over-month increase. With brand-level sales up 81.6% year over year and average price up 4.0%, this mix signals a pivot toward lower-volatility, ingestible formats even as inhalable demand softened month over month, implying SUNO’s revenue durability is increasingly tied to Tincture & Sublingual and Capsules.

The shift toward Tincture & Sublingual, combined with a 2-position context of rank 2 in Tincture & Sublingual in Arizona, positions SUNO as a dosage-led player whose growth runway depends on sustaining small month-over-month gains while defending high year-over-year expansion. The simultaneous 24.3% month-over-month decline in Concentrates against an 8.7% increase in Topical indicates a rebalancing from discretionary potency-seeking toward utility and wellness use-cases, which, paired with a 4.0% average price increase, implies pricing latitude is stronger in non-inhalable formats; maintaining Tincture & Sublingual share above 45% while stabilizing Capsules’ 17.9% month-over-month pullback would consolidate SUNO’s position as a value-accessible ingestible portfolio with less exposure to volatile inhalable cycles.

Oct-2026 Rank
Capsules
Concentrates
Tincture & Sublingual
#2
#26
#2
—
—
#6
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Tincture & Sublingual
46.6%
$13.33
+236.7%
+2.2%
Capsules
24.5%
$10.01
+55.4%
-17.9%
Concentrates
23.4%
$19.73
+0.3%
-24.3%
Topical
5.5%
$12.81
+157.2%
+8.7%
SUNO

Competitive Landscape

SUNO ranks #2 in Arizona Tincture & Sublingual for October 2026, improving 1 position year over year from #3, while holding flat versus three months prior at #2; this stability contrasts with Drip Oils + Extracts staying at #1 year over year but doing so amid a -43.27% YoY sales decline, and differs from Chronic Health slipping from #2 to #3 alongside a -65.28% YoY sales drop. Further, mid-pack churn is evident as AtoZ Botanicals climbed from #6 to #4 with a 4.28% YoY sales increase, and CBD For Life rose from #7 to #5 with a 50.04% YoY gain; against this backdrop, SUNO’s peak position at #2 in October 2026 and lack of month-to-month rank movement suggest a consolidation phase where rivals rotate around it, implying headroom to contest #1 if SUNO converts competitor declines into share capture.

SUNO category ranking vs. nearest competitors
SUNO

Notable Products

In October 2026, SUNO’s sales are concentrated: the top 10 of 25 products account for 70.9% of revenue, led by CBD Tincture (2500mg CBD) at 11.6%. That concentration sits on tinctures carrying 46.6% of brand sales, so most of its sales ride on a handful of tincture-led items.

Product
Type
Share of Sales
Avg Price
vs. Peer Avg
MoM %
CBD Tincture (2500mg CBD)
Tincture
11.6%
$15.68
—
+68.2%
Hybrid Rso Tablets 10-Pack (100mg)
Hybrid
10.0%
$9.24
-23.1%
-12.5%
Hybrid Unflavored RSO Tincture (100mg)
Tincture
8.6%
$10.02
-13.7%
+29.4%
Hybride RSO (1g)
RSO / WPE / Full Spectrum
7.6%
$20.03
+49.5%
-29.0%
CBG/CBD/THC 1:1:1 AM Tincture (100mg CBG, 100mg CBD, 100mg THC)
Tincture
6.7%
$10.34
-11.0%
-18.2%
CBD/CBN/THC 1:1:1 PM Tincture (200mg CBD, 200mg CBN, 200mg THC)
Tincture
5.8%
$21.93
+43.0%
+26.0%
THC RSO Tincture (200mg)New
Tincture
5.7%
$14.61
-4.8%
-49.1%
CBD/CBN/THC 1:1:1 PM Tablets 10-Pack (100mg CBN, 100mg CBD, 100mg THC)
CBD / CBN
5.6%
$10.17
-4.9%
-24.9%
CBD/CBG/THC 1:1:1 AM Tablets 10-Pack (100mg CBG, 100mg CBD, 100mg THC)
CBD / CBN
4.8%
$10.89
+1.9%
-15.3%
CBD/CBN/THC 1:1:1 PM Tincture (100mg CBN, 100mg CBD, 100mg THC)
Tincture
4.4%
$11.11
-4.3%
-9.2%

Peer avg: average price of the same product type and package size in the same states that month.

View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market